Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1B |
| 2 |
Merck
MRK
|
+$986M |
| 3 |
Abbott
ABT
|
+$969M |
| 4 |
NVIDIA
NVDA
|
+$967M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$814M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.46B |
| 2 |
Morgan Stanley
MS
|
+$910M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$909M |
| 4 |
Coca-Cola
KO
|
+$745M |
| 5 |
Arista Networks
ANET
|
+$692M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.51% |
| 2 | Technology | 19.42% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.08% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
OP Bancorp
OPBK
$235M
| $2.76M | ﹤0.01% |
327,407
-3,565
| -1% | -$30.2K |
|
1352
State Street SPDR S&P International Small Cap ETF
GWX
$894M
| $2.75M | ﹤0.01% |
90,244
+15,194
| +20% | +$470K |
|
1353
Oneok
OKE
$55.2B
| $2.75M | ﹤0.01% |
44,577
+40,049
| +884% | +$2.48M |
|
1354
Fortinet
FTNT
$123B
| $2.74M | ﹤0.01% |
36,302
-1,763
| -5% | -$120K |
|
1355
Stanley Black & Decker
SWK
$15.5B
| $2.73M | ﹤0.01% |
29,183
-31,882
| -52% | -$2.64M |
|
1356
Lam Research
LRCX
$398B
| $2.69M | ﹤0.01% |
41,910
-201,160
| -83% | -$11.3M |
|
1357
Zions Bancorporation
ZION
$10.5B
| $2.68M | ﹤0.01% |
+99,662
| New | +$2.76M |
|
1358
Build-A-Bear
BBW
$430M
| $2.67M | ﹤0.01% |
+124,600
| New | +$2.72M |
|
1359
State Street SPDR S&P Biotech ETF
XBI
$9.92B
| $2.66M | ﹤0.01% |
32,012
-2,100
| -6% | -$176K |
|
|
FISV
1360
Fiserv Inc
FISV
$29.7B
| $2.66M | ﹤0.01% |
21,105
+16,703
| +379% | +$1.97M |
|
1361
Edgewise Therapeutics
EWTX
$4.81B
| $2.64M | ﹤0.01% |
340,906
| – | – |
|
|
RDUS
1362
DELISTED
Radius Recycling
RDUS
| $2.64M | ﹤0.01% |
88,044
-559
| -0.6% | -$16.8K |
|
1363
Equity Residential
EQR
$25.4B
| $2.64M | ﹤0.01% |
40,022
-1,420,328
| -97% | -$88.8M |
|
1364
Travelers Companies
TRV
$78.7B
| $2.64M | ﹤0.01% |
15,187
-891
| -6% | -$157K |
|
|
RNAM
1365
DELISTED
Avidity Biosciences
RNAM
| $2.61M | ﹤0.01% |
235,236
+91,366
| +64% | +$1.15M |
|
1366
Shinhan Financial Group
SHG
$33.6B
| $2.6M | ﹤0.01% |
99,629
-774
| -0.8% | -$20.6K |
|
1367
EVgo
EVGO
$244M
| $2.57M | ﹤0.01% |
643,203
-376,428
| -37% | -$1.92M |
|
1368
Midland States Bancorp
MSBI
$717M
| $2.5M | ﹤0.01% |
125,321
-7,891
| -6% | -$159K |
|
1369
CAE Inc. Common Shares
CAE
$8.62B
| $2.49M | ﹤0.01% |
111,198
-4,137,942
| -97% | -$91.6M |
|
1370
Strategy Inc
MSTR
$35.7B
| $2.48M | ﹤0.01% |
72,500
+30,700
| +73% | +$930K |
|
1371
Cooper Companies
COO
$14.6B
| $2.48M | ﹤0.01% |
25,888
+13,752
| +113% | +$1.29M |
|
|
ZINGU
1372
DELISTED
FTAC Zeus Acquisition Corp. Unit
ZINGU
| $2.48M | ﹤0.01% |
238,487
-77,008
| -24% | -$799K |
|
1373
Alpha and Omega Semiconductor
AOSL
$1.01B
| $2.48M | ﹤0.01% |
+75,500
| New | +$2.03M |
|
|
GLDD
1374
DELISTED
Great Lakes Dredge & Dock
GLDD
| $2.47M | ﹤0.01% |
303,085
+15,090
| +5% | +$97.9K |
|
1375
Deluxe
DLX
$1.24B
| $2.47M | ﹤0.01% |
141,479
-7,486
| -5% | -$117K |
|
Similar funds
Wellington Management Group's Q2 2023 Portfolio in Review
As of Q2 2023, Wellington Management Group held 2,099 positions worth $527B, up 4.5% from $505B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Wellington Management Group's Q2 2023 filing shows 119 new, 718 increased, 815 reduced and 304 closed positions. Its largest new stake was Kenvue: 10,602,707 shares worth $280M. The largest sale was Eli Lilly, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q2 2023 buy was Kenvue: 10,602,707 shares worth $280M.
- Wellington Management Group added most to Gilead Sciences in Q2 2023, an estimated $1B increase.
- Wellington Management Group's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $2.46B.
- Wellington Management Group fully exited Syneos Health, Inc. Class A Common Stock in Q2 2023, selling an estimated $267M.
- Wellington Management Group's ten largest holdings make up 20% of its $527B portfolio in Q2 2023.
- Wellington Management Group opened 119 new positions and closed 304 in Q2 2023.
- Wellington Management Group's portfolio value rose 4.5% quarter-over-quarter to $527B.
Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.